Biocon’s Yesintek gains market entry into nine high-growth markets, expanding its global biosimilar reach through a settlement with Janssen Sciences Ireland.
If you stand at a chemist counter in Delhi for half an hour, you'll notice something. A good share of what people ask for is skin related: a cream for a rash that won't go
Tricog strengthens ties with Sanofi and OMRON Healthcare to advance Indian cardiac innovation, expand global reach and improve access to early diagnosis.
Abbott plans a nutrition spin-off by 2027 while cutting its 2026 sales growth forecast, reshaping its healthcare portfolio and growth strategy.
Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, today announced the acquisition of Energon Labs, a cGMP-compliant, USFDA-inspected, ISO 9001:2015 and ISO 17025:2017 certified analytical testing laboratory
Sun Pharma’s $355M acquisition of Unloxcyt gains momentum as the therapy earns NCCN Category 2A status for locally advanced skin cancer.
Bajaj Healthcare Q2 Results for FY27 show strong growth in revenue and profitability, supported by rising API exports and formulations sales.
Neovii Biotech and VINS Bioproducts plan immunoglobulin collaboration with technology transfer to India, potentially strengthening domestic biologics manufacturing and transplant care.
Novo Nordisk’s 35 percent growth hormone drug price cut in India puts treatment affordability and access in focus.
AstraZeneca pays USD 40 million for AI drug targets, partnering with insitro to advance discovery for liver and heart diseases.
.jpg)
, CDSCO.jpg)
